Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome
- PMID: 12084597
- DOI: 10.1016/s0735-1097(02)01894-6
Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome
Abstract
Objectives: This study compared the effects of beta-blockade on transmural and spatial dispersion of repolarization (TDR and SDR, respectively) between the LQT1 and LQT2 forms of congenital long QT syndrome (LQTS).
Background: The LQT1 form is more sensitive to sympathetic stimulation and more responsive to beta-blockers than either the LQT2 or LQT3 forms.
Methods: Eighty-seven-lead, body-surface electrocardiograms (ECGs) were recorded before and after epinephrine infusion (0.1 microg/kg body weight per min) in the absence and presence of oral propranolol (0.5-2.0 mg/kg per day) in 11 LQT1 patients and 11 LQT2 patients. The Q-T(end) interval, the Q-T(peak) interval and the interval between T(peak) and T(end) (T(p-e)), representing TDR, were measured and averaged from 87-lead ECGs and corrected by Bazett's method (corrected Q-T(end) interval [cQT(e)], corrected Q-T(peak) interval [cQT(p)] and corrected interval between T(peak) and T(end) [cT(p-e)]). The dispersion of cQT(e) (cQT(e)-D) was obtained among 87 leads and was defined as the interval between the maximum and minimum values of cQT(e).
Results: Propranolol in the absence of epinephrine significantly prolonged the mean cQT(p) value but not the mean cQT(e) value, thus decreasing the mean cT(p-e) value in both LQT1 and LQT2 patients; the differences with propranolol were significantly larger in LQT1 than in LQT2 (p < 0.05). The maximum cQT(e), minimum cQT(e) and cQT(e)-D were not changed with propranolol. Propranolol completely suppressed the influence of epinephrine in prolonging the mean cQT(e), maximum cQT(e) and minimum cQT(e) values, as well as increasing the mean cT(p-e) and cQT(e)-D values in both groups.
Conclusions: Beta-blockade under normal sympathetic tone produces a greater decrease in TDR in the LQT1 form than in the LQT2 form, explaining the superior effectiveness of beta-blockers in LQT1 versus LQT2. Beta-blockers also suppress the influence of sympathetic stimulation in increasing TDR and SDR equally in LQT1 and LQT2 syndrome.
Similar articles
-
Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.Curr Pharm Des. 2005;11(12):1561-72. doi: 10.2174/1381612053764823. Curr Pharm Des. 2005. PMID: 15892662 Free PMC article. Review.
-
Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome.J Am Coll Cardiol. 2001 Mar 1;37(3):911-9. doi: 10.1016/s0735-1097(00)01200-6. J Am Coll Cardiol. 2001. PMID: 11693770
-
Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.J Am Coll Cardiol. 2000 Mar 1;35(3):778-86. doi: 10.1016/s0735-1097(99)00582-3. J Am Coll Cardiol. 2000. PMID: 10716483
-
Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome.Eur Heart J. 2002 Jun;23(12):975-83. doi: 10.1053/euhj.2001.3079. Eur Heart J. 2002. PMID: 12069453
-
Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.J Electrocardiol. 1999;32 Suppl:177-84. doi: 10.1016/s0022-0736(99)90077-8. J Electrocardiol. 1999. PMID: 10688323 Review.
Cited by
-
Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.Curr Pharm Des. 2005;11(12):1561-72. doi: 10.2174/1381612053764823. Curr Pharm Des. 2005. PMID: 15892662 Free PMC article. Review.
-
German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management.Clin Res Cardiol. 2019 Jun;108(6):577-599. doi: 10.1007/s00392-018-1377-1. Epub 2018 Oct 10. Clin Res Cardiol. 2019. PMID: 30306295 Review.
-
Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up.HeartRhythm Case Rep. 2021 Dec 11;8(3):191-194. doi: 10.1016/j.hrcr.2021.12.006. eCollection 2022 Mar. HeartRhythm Case Rep. 2021. PMID: 35492848 Free PMC article. No abstract available.
-
Differential diagnosis between LQT1 and LQT2 by QT/RR relationships using 24-hour Holter monitoring: A multicenter cross-sectional study.Ann Noninvasive Electrocardiol. 2021 Sep;26(5):e12878. doi: 10.1111/anec.12878. Epub 2021 Jul 10. Ann Noninvasive Electrocardiol. 2021. PMID: 34245193 Free PMC article.
-
Pharmacological approach to the treatment of long and short QT syndromes.Pharmacol Ther. 2008 Apr;118(1):138-51. doi: 10.1016/j.pharmthera.2008.02.001. Pharmacol Ther. 2008. PMID: 18378319 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous